Related Experiment Video
Updated: Jul 11, 2025

08:46
Implantation of Electrospun Vascular Grafts with Optimized Structure in a Rat Model
Published on: June 27, 2018
8.0K
Remote Outcomes with Poly-ε-Caprolactone Aortic Grafts in Rats
Anna A Dokuchaeva1, Aleksandra B Mochalova1, Tatyana P Timchenko1
1Institute of Experimental Biology and Medicine, E. Meshalkin National Medical Research Center of the RF Ministry of Health, 15 Rechkunovskaya St., Novosibirsk 630055, Russia.
Polymers
|November 14, 2023
Summary
Poly-ε-caprolactone (PCL) vascular grafts remained patent in rats for 180 days, showing good revitalization but risks of mineralization and intimal hyperplasia.
Area of Science:
- Biomaterials Science
- Vascular Surgery
- Regenerative Medicine
Background:
- Poly-ε-caprolactone (PCL) is a biodegradable polymer utilized in bioengineering.
- Long-term PCL performance is influenced by application, structure, and environment.
- Vascular graft behavior requires extensive in vivo evaluation.
Purpose of the Study:
- To assess the 180-day outcomes of Poly-ε-caprolactone (PCL) tubular grafts for abdominal aorta replacement in a rat model.
- To investigate tissue reactions, graft patency, and degradation characteristics of PCL grafts.
- To identify potential advantages and disadvantages of PCL for vascular applications.
Main Methods:
- Implantation of PCL vascular matrices into adult Wistar rats.
- 180-day observation period with ultrasound diagnostics and X-ray tomography (CBCT).
- Histological analysis, immunohistochemical (IHC) staining for S100 proteins, and EDS mapping.
Main Results:
- PCL grafts maintained patency without thrombosis or leakage throughout the 180-day study.
- Endothelialization and neointimal hyperplasia were observed in all grafts.
- Subintimal calcium phosphate deposits and foreign body reactions were noted, correlating with mineralization and chondroid metaplasia.
Conclusions:
- PCL vascular scaffolds demonstrate advantages in permeability, revitalization, and surgical outcomes.
- Key disadvantages include slow biodegradation rates and significant risks of mineralization and intimal hyperplasia.
- Further research is needed to mitigate PCL's drawbacks for long-term vascular applications.

